CHIMERIC AUTOANTIBODY RECEPTOR (CAAR) T CELLS AS INNOVATIVE TREATMENT OF ACHR ANTIBODY POSITIVE MYASTHENIA GRAVISN. Von Wardenburg,S. M. Reincke, M. A. Homeyer, S. Bandura, N. Lelievre, A. Pelz, A. Meisel, H. PruessHUMAN GENE THERAPY(2022)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要